Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 7 | 2024 | 889 | 0.970 |
Why?
|
| Brain Waves | 3 | 2019 | 47 | 0.790 |
Why?
|
| Electroencephalography | 8 | 2024 | 907 | 0.500 |
Why?
|
| Seizures | 5 | 2023 | 892 | 0.500 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2023 | 235 | 0.460 |
Why?
|
| Sulfite Oxidase | 1 | 2014 | 4 | 0.440 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2014 | 30 | 0.440 |
Why?
|
| Stiff-Person Syndrome | 1 | 2014 | 5 | 0.440 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 110 | 0.400 |
Why?
|
| Electrocorticography | 2 | 2024 | 74 | 0.380 |
Why?
|
| Anticonvulsants | 2 | 2016 | 390 | 0.380 |
Why?
|
| Spasms, Infantile | 1 | 2014 | 175 | 0.380 |
Why?
|
| Mutation | 2 | 2016 | 6226 | 0.350 |
Why?
|
| Laser Therapy | 2 | 2023 | 232 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1133 | 0.330 |
Why?
|
| Epilepsies, Partial | 2 | 2021 | 95 | 0.310 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 481 | 0.230 |
Why?
|
| Hemispherectomy | 1 | 2023 | 26 | 0.200 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 124 | 0.180 |
Why?
|
| Brain Mapping | 2 | 2024 | 402 | 0.160 |
Why?
|
| Cortical Synchronization | 1 | 2019 | 12 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 19 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3843 | 0.140 |
Why?
|
| Connectome | 1 | 2019 | 116 | 0.140 |
Why?
|
| Brain | 3 | 2024 | 3182 | 0.130 |
Why?
|
| Child Development | 1 | 2019 | 271 | 0.130 |
Why?
|
| Nerve Net | 1 | 2019 | 263 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2016 | 102 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1500 | 0.120 |
Why?
|
| Amobarbital | 1 | 2015 | 3 | 0.110 |
Why?
|
| Child | 8 | 2023 | 25765 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 311 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2015 | 119 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2023 | 14736 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 136 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 560 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 590 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 654 | 0.100 |
Why?
|
| Disease Progression | 1 | 2019 | 2226 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2023 | 17374 | 0.090 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2012 | 14 | 0.090 |
Why?
|
| Biological Clocks | 1 | 2012 | 29 | 0.090 |
Why?
|
| Adolescent | 5 | 2019 | 20544 | 0.090 |
Why?
|
| Drug Resistance, Multiple | 1 | 2011 | 55 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 106 | 0.080 |
Why?
|
| Humans | 14 | 2024 | 132013 | 0.080 |
Why?
|
| Microcephaly | 1 | 2011 | 351 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2011 | 793 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2011 | 415 | 0.070 |
Why?
|
| Male | 7 | 2023 | 64914 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2011 | 569 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2011 | 569 | 0.060 |
Why?
|
| Prognosis | 2 | 2019 | 5008 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 755 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 2911 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2014 | 8542 | 0.050 |
Why?
|
| Benchmarking | 1 | 2024 | 138 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9952 | 0.050 |
Why?
|
| Female | 6 | 2022 | 70643 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 297 | 0.050 |
Why?
|
| Magnetoencephalography | 1 | 2021 | 46 | 0.050 |
Why?
|
| Artifacts | 1 | 2022 | 114 | 0.040 |
Why?
|
| Phenotype | 1 | 2011 | 4526 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 12987 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 31563 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 105 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 131 | 0.040 |
Why?
|
| Periodicity | 1 | 2018 | 50 | 0.030 |
Why?
|
| Aggression | 1 | 2019 | 227 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 177 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 3008 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2015 | 27 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2015 | 135 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2015 | 192 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 430 | 0.030 |
Why?
|
| Language | 1 | 2015 | 224 | 0.020 |
Why?
|
| Infant | 2 | 2023 | 13050 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1671 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3402 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 266 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 772 | 0.020 |
Why?
|
| Mosaicism | 1 | 2011 | 250 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 578 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 28968 | 0.010 |
Why?
|